Clinical Trial Update: Research for the Molecular Imaging of the HER2 Targeting Tracer [NA]

View source ↗

Summary

This is a clinical trial update for a HER2-targeting molecular imaging tracer, sponsored by Peking University Cancer Hospital & Institute, currently recruiting …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumors

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: HER2 Positive or Suspicious Positive Tumors | NA | Status: RECRUITING